Bactiguard Holding AB
STO:BACTI B
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
33.4
93.9
|
| Price Target |
|
We'll email you a reminder when the closing price reaches SEK.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Bactiguard Holding AB
Bactiguard Holding AB
Total Current Liabilities
Bactiguard Holding AB
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Bactiguard Holding AB
STO:BACTI B
|
Total Current Liabilities
kr261.4m
|
CAGR 3-Years
94%
|
CAGR 5-Years
36%
|
CAGR 10-Years
N/A
|
|
|
O
|
OssDsign AB
STO:OSSD
|
Total Current Liabilities
kr47.3m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
|
Xvivo Perfusion AB
STO:XVIVO
|
Total Current Liabilities
kr150.8m
|
CAGR 3-Years
34%
|
CAGR 5-Years
17%
|
CAGR 10-Years
25%
|
|
|
D
|
Doxa AB
STO:DOXA
|
Total Current Liabilities
kr228.1m
|
CAGR 3-Years
182%
|
CAGR 5-Years
126%
|
CAGR 10-Years
58%
|
|
|
V
|
Vimian Group AB
STO:VIMIAN
|
Total Current Liabilities
€93.6m
|
CAGR 3-Years
19%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
S
|
S2Medical AB (publ)
STO:S2M
|
Total Current Liabilities
kr7.5m
|
CAGR 3-Years
15%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
Bactiguard Holding AB
Glance View
Bactiguard Holding AB is a medical device company, which engages in the development and supply of infection protection solutions. The company is headquartered in Stockholm, Stockholm and currently employs 188 full-time employees. The company went IPO on 2014-06-19. Its technology is based on the Bactiguard Infection Protection (BIP), a thin coating permanently bound to the surface of medical devices. The company consists of the noble metals: gold, palladium and silver, which reduces the adhesion of bacteria to the coated surfaces. Its product portfolio includes: BIP Foley Catherer, made from medical grade latex, and BIP Foley Catheter - Silicone, used for drainage and irrigation of the bladder; BIP Endotracheal Tube, for general anesthesia, intensive care, and emergency medicine for airway management and mechanical ventilation; and BIP Central Venous Catherer, made of polyurethane and used to administer drugs and intravenous solutions, monitor pressure and blood sampling. The firm is also present in Portugal, via a distribution agreement with Socime Medical Ltd, and Zambia.
See Also
What is Bactiguard Holding AB's Total Current Liabilities?
Total Current Liabilities
261.4m
SEK
Based on the financial report for Dec 31, 2023, Bactiguard Holding AB's Total Current Liabilities amounts to 261.4m SEK.
What is Bactiguard Holding AB's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
36%
Over the last year, the Total Current Liabilities growth was 210%. The average annual Total Current Liabilities growth rates for Bactiguard Holding AB have been 94% over the past three years , 36% over the past five years .
You don't have any saved screeners yet
